COMMERZBANK AKTIENGESELLSCHAFT /FI - RAPTOR PHARMACEUTICAL CORP ownership

Quarter-by-quarter ownership
COMMERZBANK AKTIENGESELLSCHAFT /FI ownership history of RAPTOR PHARMACEUTICAL CORP
ValueSharesWeighting
Q2 2016$77,000
-6.1%
14,422
-19.3%
0.00%0.0%
Q1 2016$82,000
+12.3%
17,864
+27.1%
0.00%0.0%
Q4 2015$73,000
-57.3%
14,058
-5.3%
0.00%0.0%
Q2 2014$171,000
-58.4%
14,842
-63.9%
0.00%
-50.0%
Q1 2014$411,000
+66.4%
41,057
+158.9%
0.00%
+100.0%
Q4 2013$247,00015,8570.00%
Other shareholders
RAPTOR PHARMACEUTICAL CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Trellus Management Company, LLC 63,500$1,003,0001.13%
Broadfin Capital, LLC 1,319,883$20,841,0001.12%
BAILARD, INC. 160,000$2,526,0000.39%
Birchview Capital, LP 46,000$726,0000.38%
HIGHLAND CAPITAL MANAGEMENT LP 1,182,167$18,666,0000.38%
Rock Springs Capital Management LP 305,000$4,816,0000.35%
SPHERA FUNDS MANAGEMENT LTD. 206,500$3,261,0000.32%
GLOBEFLEX CAPITAL L P 109,771$1,733,0000.32%
GROUP ONE TRADING, L.P. 1,319,766$20,839,0000.29%
Perceptive Advisors 264,204$4,172,0000.25%
View complete list of RAPTOR PHARMACEUTICAL CORP shareholders